Novartis vs Roche vs Nestlé
Side-by-side comparison of 3 dividend stocks — yield, growth, safety.
Reviewed byLupe Editorial
·Data refreshed
·SourceEOD Historical Data — Dividends, EOD Historical Data — Fundamentals, EOD Historical Data
| Metric | Novartis CH0012005267 | Roche CH0012032048 | Nestlé CH0038863350 |
|---|---|---|---|
| Sector | Health Care | Health Care | Consumer Staples |
| Country | CH | CH | CH |
| Market Cap | – | – | – |
| Current Price | $113.30 | CHF 312.00 | CHF 77.48 |
| Dividend Yield | 3.27% | 3.14% | 4.00% |
| Dividend (TTM) | $3.70 | CHF 9.80 | CHF 3.10 |
| Increase Streak | 26 yrs | 26 yrs | 24 yrs |
| Growth (5y CAGR) | 3.48% | 1.51% | 2.47% |
| Frequency | Final | Final | Final |
| Next Ex-Date | – | – | – |
| Payout Ratio | – | – | – |
| FCF Coverage | – | – | – |
| Net Debt / EBITDA | – | – | – |
| Safety Score | 22/100 | 22/100 | 19/100 |
| Verdict | Monitor | Monitor | Monitor |
★ marks the best value in each metric. Note: for payout ratio and leverage, lower is better.
Dividend Growth Comparison
Indexed to 100 in 2011. Compares growth rates regardless of currency or size.